Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025

 

Rosa Alba Pugliesi | Health Professions | Best Researcher Award

Posted on by Shen Awards

Mrs. Rosa Alba Pugliesi | Health Professions | Best Researcher Award

University of Palermo from Italy

Dr. Rosa Alba Pugliesi is a distinguished radiologist and clinical researcher with a robust academic and professional background. She is currently pursuing a PhD at the Department of Biomedicine, Neuroscience, and Advanced Diagnostics (BiND) at the University of Palermo, Italy. Her academic journey includes a Master of Science in Clinical Research from Harvard T.H. Chan School of Public Health and Dresden International University, as well as a degree in Medicine and Surgery from the University of Palermo, where she graduated with first-class honors. Dr. Pugliesi’s clinical expertise is complemented by her extensive research in radiology, particularly focusing on imaging techniques, liver transplantation, and pediatric radiology. She has contributed to numerous peer-reviewed publications and has presented her work at various international conferences. Her commitment to medical education is evident through her role as a Teaching Assistant at Harvard, where she was recognized with the Outstanding Teaching Assistant award in 2022. Dr. Pugliesi’s multilingual abilities and international experience enhance her collaborative approach to research and clinical practice.

Professional Profile

Education

Dr. Pugliesi’s educational background is marked by excellence and a commitment to continuous learning. She began her academic journey at the Scientific High School in Palermo, achieving the highest grade awarded. She then pursued a degree in Medicine and Surgery at the University of Palermo, graduating with first-class honors (cum laude). Her passion for research led her to obtain a Master of Science in Clinical Research from Harvard T.H. Chan School of Public Health and Dresden International University. Furthering her expertise, she completed the ESR Master Class in Artificial Intelligence. Currently, she is a PhD candidate at the Department of Biomedicine, Neuroscience, and Advanced Diagnostics (BiND) at the University of Palermo, focusing on advanced diagnostics in radiology. Her educational pursuits reflect a dedication to integrating clinical practice with cutting-edge research methodologies.

Professional Experience

Dr. Pugliesi’s professional journey encompasses a blend of clinical practice and academic involvement. She is a board-certified radiologist in Germany, having completed her residency at Ludwigsburg’s Hospital and Stuttgart’s Hospital. Her clinical experience includes roles as a Clinical Research Associate at Northwestern University and an Internal Medicine Resident at Hassfurt’s Hospital in Germany. In academia, she served as a Teaching Assistant at Harvard T.H. Chan School of Public Health, contributing to the development of clinical research training programs. Her international exposure includes fellowships and clerkships in Mexico, Romania, and Austria, enhancing her global perspective in medical practice. Dr. Pugliesi’s diverse experiences have equipped her with a comprehensive understanding of radiological practices across different healthcare systems.

Research Interests

Dr. Pugliesi’s research interests are centered around radiology and its applications in clinical diagnostics. She has a keen interest in imaging techniques related to liver transplantation, gastrointestinal disorders, and pediatric radiology. Her work often explores the efficacy of contrast agents in magnetic resonance imaging and the role of artificial intelligence in enhancing diagnostic accuracy. She is also interested in the development of non-invasive imaging methods and their integration into clinical workflows. Her research aims to bridge the gap between advanced imaging technologies and practical clinical applications, ultimately improving patient outcomes.

Research Skills

Dr. Pugliesi possesses a robust set of research skills that encompass both qualitative and quantitative methodologies. She is proficient in statistical software such as STATA, SPSS, and R, enabling her to perform complex data analyses. Her expertise includes designing clinical trials, conducting systematic reviews, and performing meta-analyses. She has experience in manuscript writing and the peer-review process, contributing to her role as a reviewer for journals like “Abdominal Radiology” and “Principle and Practice of Clinical Research.” Her technical skills are complemented by her ability to mentor students and collaborate with multidisciplinary teams, fostering a collaborative research environment.

Awards and Honors

Dr. Pugliesi’s contributions to the field have been recognized through various awards and honors. Notably, she received the Outstanding Teaching Assistant award from Harvard T.H. Chan School of Public Health in 2022, acknowledging her excellence in academic mentorship. Her research presentations have garnered accolades at international conferences, including the Next Frontier Award at the Society of Abdominal Radiology (SAR) Meeting in 2023. She has also been awarded a Certificate of Merit at the Radiological Society of North America (RSNA) in 2022. These honors reflect her commitment to advancing the field of radiology through both research and education.

Conclusion

Dr. Rosa Alba Pugliesi exemplifies the qualities of a dedicated clinician, researcher, and educator. Her comprehensive educational background, coupled with diverse professional experiences, positions her as a leader in the field of radiology. Her research contributions have significantly advanced understanding in imaging diagnostics, particularly in liver transplantation and pediatric radiology. Her commitment to education and mentorship, recognized by prestigious institutions, underscores her role in shaping future medical professionals. Dr. Pugliesi’s international experience and multilingual capabilities enhance her ability to collaborate across borders, fostering a global approach to healthcare. Her dedication to integrating clinical practice with innovative research makes her a deserving candidate for the Best Researcher Award.

Publication Top Notes

  • Title: Layering hyperintensity in T1-weighted magnetic resonance imaging predicts gallbladder sludge: a retrospective cohort and diagnostic accuracy study in patients with significant liver disease

  • Authors: Rosa Alba Pugliesi (R.A. Pugliesi), Timo Siepmann (T. Siepmann), Daniel P.O. Kaiser (D.P.O. Kaiser)

  • Year: 2025

  • Journal: Abdominal Radiology

Jiaqi Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Jiaqi Zhang | Medicine and Dentistry | Best Researcher Award

Chief resident from Peking University Third Hospital, China

Dr. Jiaqi Zhang is currently serving as Chief Resident in the Department of Orthopedics at Peking University Third Hospital. A dedicated medical professional and clinical researcher, he has established a specialized focus on spinal deformities in adults, particularly those of complex and congenital origins. With a medical degree in orthopedics from the prestigious Peking University, Dr. Zhang integrates clinical expertise with rigorous research activities. He is also actively involved in academic research as part of the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine, affiliated with China’s Ministry of Education. Dr. Zhang has contributed to peer-reviewed literature, with five published articles in SCI-indexed journals that delve into advanced diagnostic imaging and surgical outcomes. His most notable contribution lies in identifying MRI indicators for poor prognosis in patients with congenital angular kyphosis, which has practical implications in spine surgery decision-making. Though early in his research career, Dr. Zhang is committed to advancing orthopedic science and improving patient care outcomes. He continues to develop his expertise through ongoing clinical research projects and aims to expand his impact through collaborative studies and innovation in spinal surgery.

Professional Profile

Education

Dr. Jiaqi Zhang earned his Doctor of Orthopedics degree from Peking University, one of China’s most esteemed medical institutions. His education laid a robust foundation in both theoretical and practical aspects of orthopedic surgery, with a growing focus on spinal deformities during his residency years. The program provided intensive clinical training combined with exposure to academic research, enabling him to understand the intricacies of musculoskeletal disorders at both clinical and cellular levels. In addition to his core medical training, Dr. Zhang engaged in independent studies and mentored research activities that emphasized evidence-based medicine, biomechanics, and diagnostic imaging. His thesis work and research outputs during the doctoral program reflected a deep interest in the surgical management of complex spinal conditions, an area which would later become his primary research focus. Peking University’s commitment to academic excellence, interdisciplinary research, and advanced medical technologies has played a crucial role in shaping Dr. Zhang’s clinical acumen and investigative mindset. The educational environment also allowed him to build competencies in surgical planning, patient care management, and ethical clinical research, positioning him to serve effectively in both hospital and academic settings.

Professional Experience

Dr. Jiaqi Zhang currently holds the position of Chief Resident in the Department of Orthopedics at Peking University Third Hospital, a leading medical institution in China. In this capacity, he manages a wide array of clinical responsibilities, ranging from patient diagnosis and pre-operative evaluations to complex spinal surgeries and post-operative care. His role demands a high degree of precision, leadership, and the ability to make swift, informed decisions in high-pressure environments. In parallel with his clinical duties, Dr. Zhang also serves as a researcher in the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine. These appointments allow him to participate in translational research efforts focused on improving the treatment and understanding of spinal disorders. Through these roles, Dr. Zhang has been actively involved in three major clinical research projects, integrating data analysis, surgical innovation, and radiological evaluation. His clinical insights feed directly into his research questions, creating a dynamic loop between patient care and scientific discovery. Although still in the early stages of his career, Dr. Zhang has demonstrated professional maturity and a strong commitment to interdisciplinary collaboration in both clinical and academic spheres.

Research Interests

Dr. Jiaqi Zhang’s research interests are centered around the surgical treatment and pathophysiological mechanisms of adult spinal deformity, with a specialized focus on rare and complex conditions such as congenital angular kyphosis. He is particularly interested in the intersection of diagnostic imaging and surgical outcomes, seeking to improve preoperative planning through advanced radiological markers. One of his primary research goals is to develop predictive models based on MRI indicators to identify patients at higher risk of poor neurological recovery. His study of compressive myelopathy associated with severe kyphosis is a reflection of this interest, where he demonstrated the value of quantifying MRI features such as T1WI hypointensity and MTAC ratios. Dr. Zhang also aims to explore how early surgical intervention can prevent irreversible spinal cord damage, with implications for refining surgical timing and techniques. His broader interests include spinal biomechanics, spinal cord injury recovery, and minimally invasive surgical innovations. Through evidence-based practice and rigorous analysis, he aspires to contribute to the development of clinical guidelines that enhance surgical decision-making and long-term patient outcomes. Future research plans include collaborating with biomedical engineers and radiologists to explore imaging-based AI models in spine surgery.

Research Skills

Dr. Jiaqi Zhang possesses a comprehensive set of research skills that complement his clinical expertise in orthopedic surgery. He is proficient in clinical research design, patient data analysis, and statistical interpretation, particularly in relation to outcome-based studies in spinal surgery. His methodological skills are reflected in his rigorous screening of patient cohorts and meticulous evaluation of radiological parameters, such as those used in his study on congenital angular kyphosis and myelopathy. He has hands-on experience with MRI data analysis and its integration into surgical planning, which enhances both predictive and outcome assessment models. Dr. Zhang is also familiar with scientific writing, literature review methodologies, and the publication process, as evidenced by his five publications in peer-reviewed, SCI-indexed journals. While he has yet to engage in industry collaborations or patent development, he shows potential to expand his research competencies through interdisciplinary projects. Additionally, he is comfortable working with medical imaging software and clinical databases, enabling him to bridge diagnostic tools with surgical interventions. His commitment to ethical standards in clinical research and informed consent processes further strengthens his skill set. As he continues his academic and clinical journey, Dr. Zhang aims to refine his skills in grant writing, protocol development, and advanced statistical tools.

Awards and Honors

As of the current application, Dr. Jiaqi Zhang has not listed any formal awards or honors. However, his selection as Chief Resident at Peking University Third Hospital is itself indicative of his academic and professional excellence. Chief residency is typically awarded to individuals who have demonstrated exceptional clinical skills, leadership capabilities, and research promise during their training. Additionally, his role as a researcher in the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine reflects institutional recognition of his potential to contribute meaningfully to high-impact research. While he may not yet have received formal accolades such as national awards or fellowships, Dr. Zhang is on a promising trajectory. His recent publications, innovative work in MRI-based surgical prognosis, and growing presence in peer-reviewed literature may soon garner greater professional recognition. As he continues to expand his academic portfolio through additional publications, collaborative projects, and advanced studies, he is likely to become a strong candidate for future awards and honors in both national and international orthopedic research communities.

Conclusion

Dr. Jiaqi Zhang is a dedicated clinician-researcher who exemplifies a balanced integration of academic rigor and clinical acumen. His research, though still in early stages, targets a highly specialized and clinically significant area—adult spinal deformity with neurologic complications. The outcomes of his studies provide practical guidance for surgeons in managing complex cases, particularly through the use of MRI-based prognostic markers. While his profile would benefit from broader research collaborations, industry partnerships, and increased visibility through awards or society memberships, his current contributions lay a strong foundation for future growth. With five SCI-indexed publications, three active research projects, and a leadership role as Chief Resident, Dr. Zhang has demonstrated a consistent commitment to advancing orthopedic science. His ability to translate clinical challenges into research questions, coupled with his skill in data-driven analysis, positions him as a rising contributor to the field of spinal surgery. In conclusion, Dr. Jiaqi Zhang has the potential to become a leading voice in orthopedic research, provided he continues to build on his current achievements with expanded collaborations and continued innovation.

Catarina Eloy | Health Professions | Women Researcher Award

Posted on by Shen Awards

Prof. Catarina Eloy | Health Professions | Women Researcher Award

IPATIMUP, Portugal

Dr. Catarina Eloy is a distinguished pathologist and researcher specializing in digital pathology and oncologic diagnostics. She has significantly contributed to the integration of artificial intelligence (AI) in pathology, enhancing diagnostic accuracy and efficiency. As a key figure in the HEROHE Challenge, Dr. Eloy collaborated with international experts to develop AI models for predicting HER2 status in breast cancer using hematoxylin–eosin-stained whole-slide images. Her work emphasizes the importance of digital tools in modern pathology, aiming to bridge the gap between traditional histopathology and emerging computational methods. Dr. Eloy’s research has been pivotal in advancing the field, particularly in the context of the COVID-19 pandemic, where digital pathology played a crucial role in maintaining diagnostic services. Her contributions extend beyond research, as she actively participates in international collaborations and initiatives to promote the adoption of digital pathology worldwide. Dr. Eloy’s dedication to innovation and excellence has established her as a leading authority in the field, influencing both clinical practice and research methodologies in pathology.

Professional Profile

Education

Dr. Catarina Eloy’s educational background is rooted in medicine and pathology, providing a strong foundation for her career in digital pathology and oncologic diagnostics. She obtained her medical degree from a reputable institution, followed by specialized training in pathology. Her academic pursuits included advanced studies in digital pathology, where she focused on integrating computational tools with traditional histopathological techniques. Dr. Eloy’s commitment to education is evident through her involvement in various training programs and workshops aimed at disseminating knowledge in digital pathology. She has also contributed to academic literature, authoring several publications that serve as educational resources for both students and professionals in the field. Her educational journey reflects a continuous pursuit of knowledge and a dedication to advancing the field of pathology through both learning and teaching.

Professional Experience

Dr. Catarina Eloy has amassed extensive professional experience in pathology, with a particular focus on digital pathology and oncologic diagnostics. She has held key positions in various institutions, where she has been instrumental in implementing digital pathology workflows and integrating AI tools into diagnostic processes. Her professional journey includes collaborative projects like the HEROHE Challenge, where she worked alongside international experts to develop AI models for breast cancer diagnostics. Dr. Eloy has also contributed to global initiatives aimed at promoting digital pathology, especially during the COVID-19 pandemic, highlighting the importance of digital tools in maintaining diagnostic services. Her leadership and expertise have significantly influenced the adoption of digital pathology practices, enhancing diagnostic accuracy and efficiency across various healthcare settings.

Research Interests

Dr. Catarina Eloy’s research interests are centered around the integration of digital tools in pathology, with a particular emphasis on artificial intelligence and its applications in oncologic diagnostics. She is deeply involved in exploring how AI can enhance the accuracy and efficiency of pathological diagnoses, especially in breast cancer. Her work in the HEROHE Challenge exemplifies her commitment to developing AI models that can predict HER2 status from histopathological images, thereby contributing to personalized medicine. Additionally, Dr. Eloy is interested in the broader implications of digital pathology, including its role in global health and its potential to revolutionize diagnostic practices. Her research aims to bridge the gap between traditional pathology and emerging digital technologies, fostering innovation in diagnostic methodologies.

Research Skills

Dr. Catarina Eloy possesses a robust set of research skills that underpin her contributions to digital pathology and oncologic diagnostics. Her expertise includes proficiency in histopathological analysis, digital imaging, and the application of AI algorithms in diagnostic processes. She is adept at designing and conducting research studies that explore the integration of digital tools in pathology, as evidenced by her involvement in the HEROHE Challenge. Dr. Eloy is also skilled in collaborative research, working with multidisciplinary teams to advance the field of digital pathology. Her analytical capabilities and methodological rigor have been instrumental in producing high-impact research that informs both clinical practice and future studies.

Awards and Honors

Dr. Catarina Eloy’s contributions to pathology have been recognized through various awards and honors. Her work in digital pathology and AI integration has garnered international attention, leading to accolades that highlight her influence in the field. While specific awards are not detailed in the available sources, her leadership roles in significant projects like the HEROHE Challenge and her involvement in global initiatives during the COVID-19 pandemic underscore her esteemed position in the pathology community. These recognitions reflect her dedication to advancing pathology through innovation and collaboration.

Conclusion

Dr. Catarina Eloy’s career embodies a commitment to innovation, collaboration, and excellence in pathology. Her pioneering work in digital pathology and the integration of AI into diagnostic processes has significantly advanced the field, offering new avenues for accurate and efficient patient care. Through initiatives like the HEROHE Challenge, she has demonstrated the potential of interdisciplinary collaboration in developing cutting-edge diagnostic tools. Dr. Eloy’s contributions during the COVID-19 pandemic further highlight the critical role of digital pathology in maintaining healthcare services amidst global challenges. Her dedication to research, education, and professional development continues to inspire advancements in pathology, solidifying her status as a leading figure in the field.

Publications Top Notes

  • Title: Classification of breast cancer histology images using convolutional neural networks
    Authors: T. Araújo, G. Aresta, E. Castro, J. Rouco, P. Aguiar, C. Eloy, A. Polónia, …
    Journal: PLoS ONE, 12(6): e0177544
    Year: 2017
    Citations: 1162

  • Title: Bach: Grand challenge on breast cancer histology images
    Authors: G. Aresta, T. Araújo, S. Kwok, S. S. Chennamsetty, M. Safwan, V. Alex, …
    Journal: Medical Image Analysis, 56: 122–139
    Year: 2019
    Citations: 742

  • Title: TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
    Authors: M. Melo, A. G. da Rocha, J. Vinagre, R. Batista, J. Peixoto, C. Tavares, …
    Journal: The Journal of Clinical Endocrinology & Metabolism, 99(5): E754–E765
    Year: 2014
    Citations: 641

  • Title: Follicular thyroid carcinoma
    Authors: M. Sobrinho-Simões, C. Eloy, J. Magalhães, C. Lobo, T. Amaro
    Journal: Modern Pathology, 24: S10–S18
    Year: 2011
    Citations: 223

  • Title: Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas
    Authors: P. Soares, J. Lima, A. Preto, P. Castro, J. Vinagre, R. Celestino, J. P. Couto, …
    Journal: Current Genomics, 12(8): 609–617
    Year: 2011
    Citations: 127

  • Title: Best practice recommendations for the implementation of a digital pathology workflow in the anatomic pathology laboratory by the European Society of Digital and Integrative Pathology
    Authors: F. Fraggetta, V. L’imperio, D. Ameisen, R. Carvalho, S. Leh, T. R. Kiehl, …
    Journal: Diagnostics, 11(11): 2167
    Year: 2021
    Citations: 92

  • Title: NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
    Authors: C. Tavares, M. J. Coelho, C. Eloy, M. Melo, A. G. da Rocha, A. Pestana, …
    Journal: Endocrine Connections, 7(1): 78–90
    Year: 2018
    Citations: 85

  • Title: Automatic classification of tissue malignancy for breast carcinoma diagnosis
    Authors: I. Fondón, A. Sarmiento, A. I. García, M. Silvestre, C. Eloy, A. Polónia, P. Aguiar
    Journal: Computers in Biology and Medicine, 96: 41–51
    Year: 2018
    Citations: 83

  • Title: Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
    Authors: M. A. Berbís, D. S. McClintock, A. Bychkov, J. Van der Laak, L. Pantanowitz, …
    Journal: EBioMedicine, 88
    Year: 2023
    Citations: 78

  • Title: Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway
    Authors: J. M. Cameselle-Teijeiro, D. Peteiro-González, J. Caneiro-Gómez, …
    Journal: Modern Pathology, 31(8): 1168–1179
    Year: 2018
    Citations: 72

PIERRE LOFUTA OLENGA VUVU | Health Professions | Scientific Excellence Achievement Award

Posted on by Shen Awards

Dr. PIERRE LOFUTA OLENGA VUVU | Health Professions | Scientific Excellence Achievement Award

University of Kinshasa, Free University of Brussels, Belgium

Pierre Lofuta Olenga Vuvu is a Clinical Research Associate (CRA) with significant experience in managing clinical trials and ensuring adherence to Good Clinical Practice (GCP) guidelines. He has a strong background in cardiopulmonary physiology, rehabilitation, and clinical epidemiology, and has worked with multidisciplinary teams to execute and oversee research projects. Pierre is currently pursuing a Ph.D. in Health Sciences at the Université Libre de Bruxelles, Belgium, with a focus on clinical research and rehabilitation. Over the years, he has contributed to several studies in clinical trials, epidemiology, and respiratory health, further expanding his expertise in these areas. Pierre has published numerous articles in peer-reviewed journals and presented his research at international conferences. His career reflects a blend of clinical experience, research expertise, and a dedication to advancing scientific knowledge in the healthcare sector.

Professional Profile

Education

Pierre Lofuta Olenga Vuvu’s educational journey showcases a commitment to acquiring specialized knowledge in clinical research and healthcare. He is currently pursuing a Ph.D. in Health Sciences at the Université Libre de Bruxelles (ULB), with a focus on cardiopulmonary physiology and rehabilitation. Additionally, Pierre holds a specialized diploma in Clinical Epidemiology and Health Economics from the University of Liège, Belgium. He has also earned a certificate in Project Management and a certificate in Data Management and Scientific Communication from ULB. His earlier studies include an Advanced Master’s degree in Physical Medicine and Rehabilitation from the University of Kinshasa, DRC. Pierre’s educational background, combined with his ongoing research in health sciences, supports his well-rounded understanding of both clinical practice and scientific research methodologies.

Professional Experience

Pierre’s professional career spans several years of diverse roles in clinical research, clinical trials, and healthcare. Since 2020, he has served as a Clinical Research Associate at Université Libre de Bruxelles (ULB), where he has led the development and management of clinical trials in cardiopulmonary physiology and clinical epidemiology. He has worked on study protocols, data collection, patient safety, and compliance with regulatory standards. Pierre also has experience as an Epidemiologist and Research Data Manager for ULB-Cooperation, where he oversaw research projects related to respiratory health and worked on international collaborations. Earlier in his career, he worked as a clinician practitioner and lecturer in Physical Medicine and Rehabilitation at the University Hospital of Kinshasa, DRC, where he also mentored students and supervised research projects. This diverse background underscores his broad expertise in both clinical settings and research environments.

Research Interest

Pierre’s primary research interests lie in the areas of clinical epidemiology, cardiopulmonary physiology, and rehabilitation. He is particularly focused on understanding the impact of respiratory conditions, such as asthma and COPD, through clinical trials and data analysis. His research is centered around improving patient care in clinical settings and contributing to the development of evidence-based practices in the treatment and management of cardiovascular and pulmonary diseases. Additionally, Pierre has a keen interest in health economics, specifically the assessment of healthcare systems in Europe and Belgium. His ongoing Ph.D. research further explores these themes, with a focus on improving rehabilitation protocols for patients with respiratory and cardiovascular conditions.

Research Skills

Pierre is skilled in various research methodologies, including the design and implementation of clinical trials, biostatistical analysis, and data management. He is proficient in using statistical software such as SPSS, R, SAS, and GraphPad Prism for data analysis. Pierre also has expertise in regulatory compliance, adverse event reporting, and quality assurance in clinical research. His technical skills are complemented by his ability to write research protocols, study reports, and scientific publications, which contribute to his effectiveness in disseminating research findings. Additionally, Pierre has experience with clinical research systems such as Electronic Data Capture (EDC) platforms and project management tools like Microsoft Project. His ability to collaborate with multidisciplinary teams and manage research projects ensures that his work is comprehensive and impactful.

Awards and Honors

Pierre Lofuta Olenga Vuvu has received recognition for his contributions to clinical research and public health. While specific awards and honors are not listed in detail, his career trajectory reflects his commitment to excellence in clinical research and academic achievement. He has been involved in various scientific societies, such as the European Respiratory Society (ERS), and has presented his research at international conferences. His ongoing Ph.D. work and his involvement in multiple research projects demonstrate his standing in the academic and clinical research communities. Additionally, Pierre’s role in leading clinical trials and his focus on improving patient outcomes through research further underscores the significant impact he has had in his field.

Conclusion

Pierre Lofuta Olenga Vuvu is a highly accomplished Clinical Research Associate with a strong background in cardiopulmonary physiology, clinical epidemiology, and rehabilitation. His extensive experience in managing clinical trials, conducting research, and ensuring adherence to regulatory standards positions him as a leading figure in clinical research. Pierre’s academic journey, including his ongoing Ph.D. and numerous specialized certifications, reflects his commitment to continuous learning and professional development. His ability to collaborate with international stakeholders and work across multidisciplinary teams highlights his effectiveness in advancing scientific research. While there are areas for improvement, such as further expanding his publication record and refining his English proficiency, Pierre’s contributions to clinical research, his dedication to patient care, and his leadership in research projects make him a deserving candidate for recognition and continued success in his field.

Publications Top Notes

  1. Title: Effects of chronic exposure to biomass pollutants on cardiorespiratory responses and the occurrence of exercise‐induced bronchoconstriction in healthy men
    Journal: Physiological Reports
    Year: 2025
    DOI: 10.14814/phy2.70368
    Contributors: Pierre Lofuta Olenga Vuvu; Malgorzata Klass; Nathalie Pauwen; Augustin Mboko Kipula; Philippe van de Borne; Alain van Muylem; Silvia Perez‐Bogerd; Gael Deboeck

  2. Title: Occupational Exposure to Charcoal Smoke and Dust, a Major Risk Factor for COPD
    Journal: CHEST
    Year: 2024
    DOI: 10.1016/j.chest.2024.07.158
    Contributors: Pierre Olenga Vuvu Lofuta; Malgorzata Klass; Nathalie Pauwen; Augustin Mboko Kipula; Philippe van de Borne; Alain Van Muylem; Silvia Perez-Bogerd; Gaël Deboeck

Lakovos Nomikos | Health Professions | Outstanding Scientist Award

Posted on by Shen Awards

Prof. Dr. Lakovos Nomikos | Health Professions | Outstanding Scientist Award

MD, PhD, FACS from European University Cyprus Nicosia Cyprus, Rea Maternity Hospital Athens Greece, Greece

Dr. Iakovos N. Nomikos, MD, PhD, FACS, is a distinguished academic surgeon with over four decades of experience in clinical practice, research, and medical education. Born on October 1, 1951, in Greece, Dr. Nomikos has dedicated his career to advancing surgical science, with particular contributions in the fields of transplantation biology, metabolic support for critical illness, and oncologic surgery. He has held significant roles in both academic and hospital settings, including Assistant Professor and Chairman of Surgery at major institutions. His extensive training includes fellowships in the United States and the United Kingdom, reflecting a broad international perspective and collaboration. Dr. Nomikos is a Fellow of the American College of Surgeons and a respected member of multiple medical societies. His work spans a wide range of clinical and research domains, and he is widely recognized for his mentorship, leadership, and commitment to the integration of scientific innovation into surgical practice. His contributions have been presented in international conferences, lectures, and numerous publications in both Greek and English literature. Dr. Nomikos continues to serve as an adjunct professor, influencing the next generation of medical professionals while remaining actively engaged in clinical and academic research.

Professional Profile

Education

Dr. Iakovos N. Nomikos pursued his early education at the “Gymnasium” High School in Syros, Cyclades, Greece, from 1963 to 1969, graduating with excellence. He then entered the Medical School of Athens University, where he studied from 1969 to 1975. His academic record was exemplary, achieving an “excellency” degree. The medical program at Athens University included an integrated internship in the final year, consisting of clinical rotations in internal medicine, surgery, pediatrics, and obstetrics-gynecology. This foundational training provided him with a solid grounding in multiple medical disciplines. Following his medical degree, Dr. Nomikos completed a residency in General Surgery at “Evagelismos” Medical Center in Athens from 1975 to 1980. His postgraduate education continued through prestigious fellowships in surgical nutrition, transplantation biology, critical care, and hepatobiliary surgery at world-renowned institutions such as the University of Colorado Health Sciences Center, New York Medical College, and The Queen Elizabeth Hospital in Birmingham, England. These advanced studies and international experiences significantly enriched his clinical knowledge and research capabilities, positioning him as a leader in surgical education and innovation. His diverse academic training has underpinned a career defined by scientific inquiry, clinical excellence, and global collaboration.

Professional Experience

Dr. Nomikos’s professional career spans several decades, marked by progressive responsibility and distinction in surgical practice and academic leadership. His early career began with positions as an attending surgeon at Evangelismos Medical Center and Larissa General Hospital in Greece. From 1987 to 2004, he served in the Department of Surgery at Tzanion General Hospital, Piraeus, progressing from attending surgeon to associate director. In 2004, he was appointed Chairman of Surgery at Metaxa Cancer Memorial Hospital, where he served until 2018, overseeing clinical operations, research, and resident education. Since 2019, he has continued practicing surgery in the private sector at Rea Maternity Hospital and Metropolitan General Hospital in Athens. In parallel with his clinical duties, Dr. Nomikos has held academic positions, including Lecturer and Assistant Professor of Surgery at Athens University and currently serves as Adjunct Professor of Surgery at the European University of Cyprus. His teaching responsibilities span both the School of Medicine and the Department of Life Sciences. Throughout his career, he has played a vital role in shaping surgical education programs and mentoring young professionals. His leadership has consistently integrated evidence-based practice with clinical innovation, reinforcing his reputation as a pillar of surgical excellence in Greece and beyond.

Research Interests

Dr. Iakovos N. Nomikos has cultivated a robust and diverse research portfolio throughout his career, combining basic science with applied clinical studies. His early research focused on transplantation biology, with particular emphasis on pancreatic islet transplantation for insulin-dependent diabetes mellitus (IDDM), examining graft destruction mechanisms. He has also extensively studied ischemia-reperfusion injury, a critical area in transplantation and trauma surgery. Another major area of interest includes the cellular biology of peritonitis, where he has investigated immune response and inflammation in abdominal infections. In applied research, Dr. Nomikos has addressed practical clinical challenges such as peritoneal infections, neo-adjuvant chemotherapy for solid tumors, metabolic responses in critically ill surgical patients, and functional staging of acute surgical illness. His interest in surgical metabolism and nutrition has informed clinical protocols that improve recovery and outcomes in post-operative and intensive care settings. These research interests not only highlight his interdisciplinary approach but also reflect a commitment to enhancing surgical care through scientific advancement. Dr. Nomikos’s work stands at the intersection of innovation and clinical relevance, aiming to translate laboratory discoveries into improved patient outcomes. His efforts have contributed significantly to the fields of surgical oncology, critical care, and transplant medicine.

Research Skills

Dr. Nomikos brings an exceptional set of research skills developed through decades of clinical practice, international training, and academic scholarship. His expertise spans both bench-side experimentation and bedside clinical research. In basic science, he is skilled in experimental models of islet transplantation, immunological assays, and the study of cellular mechanisms involved in ischemia-reperfusion injury and peritonitis. His training in the United States and the UK equipped him with advanced competencies in surgical research methodologies, including critical care and transplant-related studies. In clinical research, he excels in protocol development, data analysis, clinical trial execution, and outcome evaluation, particularly in surgical oncology and critical care settings. He has led and participated in projects focusing on chemotherapy protocols, surgical metabolic support, and the functional assessment of acute surgical conditions. Dr. Nomikos is also adept at medical writing, scientific presentation, and research mentoring, contributing significantly to academic publications, oral communications, and educational leadership. His ability to bridge theoretical science with surgical practice exemplifies translational research at its best. These multifaceted skills have enabled him to drive innovations in patient care, guide clinical decision-making, and mentor a generation of surgeon-scientists within Greece and internationally.

Awards and Honors

Dr. Iakovos N. Nomikos has received numerous honors and awards in recognition of his exceptional contributions to surgery, research, and education. He is a Fellow of the American College of Surgeons (FACS), a prestigious international credential that signifies excellence in surgical practice and ethics. His career achievements have been acknowledged through several institutional, national, and international recognitions, including leadership positions in major hospitals and academic programs. He has been honored for his work in surgical oncology, critical care, and transplantation science. Dr. Nomikos’s scholarly efforts have been consistently featured in leading international congresses, where he has delivered invited lectures, chaired roundtable discussions, and presented scientific exhibits. His teaching accomplishments have also been recognized by academic institutions where he has played a pivotal role in curriculum development and resident training. Moreover, his influence extends through professional societies, where he holds memberships that reflect both his scientific stature and dedication to interdisciplinary collaboration. These accolades collectively underscore a career marked by lifelong service to advancing surgical science and mentoring future generations of clinicians. His awards affirm his lasting impact on both the academic and medical communities, validating his status as a respected leader in the global surgical field.

Conclusion

Dr. Iakovos N. Nomikos exemplifies the ideal candidate for recognition through a Research for Outstanding Scientist Award. His career is defined by a seamless integration of academic rigor, clinical excellence, and translational research. From pioneering studies in transplantation biology to practical innovations in critical care and oncologic surgery, he has consistently addressed key challenges in surgical practice through scientific inquiry. His mentorship, leadership, and continued contributions as an adjunct professor demonstrate ongoing relevance and impact. With a history of productive research collaborations, international training, and a strong publication and presentation record, Dr. Nomikos has significantly advanced both theoretical and applied surgical knowledge. Although further visibility through recent high-impact publications or patent disclosures could strengthen his profile, the depth, breadth, and longevity of his contributions are clear. He has made lasting advancements in patient care, surgical methodology, and medical education. In conclusion, Dr. Nomikos’s distinguished achievements over several decades merit recognition not only as a leading figure in his field but also as a scientist whose work has tangibly improved lives and enriched the broader medical community. His career is a model of what sustained excellence and dedication in clinical research can accomplish.

Publications Top Notes

  • Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice
    Authors: IN Nomikos, SJ Prowse, P Carotenuto, KJ Lafferty
    Journal: Diabetes, 35(11), 1302–1304
    Citations: 159
    Year: 1986

  • Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation
    Authors: R Omar, I Nomikos, G Piccorelli, J Savino, N Agarwal
    Journal: Gut, 30(4), 510–514
    Citations: 139
    Year: 1989

  • Involvement of O2 radicals in ‘autoimmune’ diabetes
    Authors: IN Nomikos, Y Wang, KJ Lafferty
    Journal: Immunology and Cell Biology, 67(1), 85–87
    Citations: 97
    Year: 1989

  • Washing with or without chloramphenicol in the treatment of peritonitis: a prospective, clinical trial
    Authors: IN Nomikos, K Katsouyanni, AN Papaioannou
    Journal: Surgery, 99(1), 20–25
    Citations: 64
    Year: 1986

  • Effect of cyclosporine on immunologically mediated diabetes in nonobese diabetic mice
    Authors: Y Wang, M McDuffie, IN Nomikos, L Hao, KJ Lafferty
    Journal: Transplantation, 46(2), 101S–106S
    Citations: 49
    Year: 1988

  • Current surgical aspects of palliative treatment for unresectable pancreatic cancer
    Authors: K Karapanos, IN Nomikos
    Journal: Cancers, 3(1), 636–651
    Citations: 28
    Year: 2011

  • Protective and damaging aspects of healing: A review
    Authors: IN Nomikos, C Malizos, NC Vamvakopoulos
    Journal: Wounds: A Compendium of Clinical Research and Practice, 18(7), 177–185
    Citations: 28
    Year: 2006

  • Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery
    Authors: N Perrakis, E Athanassiou, D Vamvakopoulou, M Kyriazi, H Kappos, …
    Journal: World Journal of Gastroenterology, 17(35), 4013
    Citations: 27
    Year: 2011

  • Carcinoma of the inguinal region arising from endometriosis of the round ligament. Report of a case
    Authors: J Elemenoglou, A Skopelitou, I Nomikos
    Journal: European Journal of Gynaecological Oncology, 14(1), 28–32
    Citations: 27
    Year: 1993

  • Tamoxifen-induced endometrial polyp. A case report and review of the literature
    Authors: IN Nomikos, J Elemenoglou, J Papatheophanis
    Journal: European Journal of Gynaecological Oncology, 392, 2936
    Citations: 23
    Year: 1998

Christine Shaw | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Christine Shaw| Medicine and Dentistry | Best Researcher Award

Dr. Christine Shaw University of Alabama Birmingham, United States.

Dr. Christine M. Shaw is an Instructor and GEM/SEMPH Fellow in the Department of Emergency Medicine at the University of Alabama at Birmingham. She holds an MD from the Medical University of South Carolina and advanced degrees in public health and tropical medicine. Her clinical work spans both adult and pediatric emergency medicine at UAB Hospital and Children’s of Alabama. A passionate researcher and educator, Dr. Shaw has received multiple awards for her work in emergency care, homelessness, health equity, and global medicine. She has presented at national conferences and co-founded several community and educational initiatives. Her commitment to underserved populations and academic excellence makes her a strong candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Christine Shaw holds an MSPH (Master of Science in Public Health) from the UAB School of Public Health (2025 expected), a Diploma in Tropical Medicine and Hygiene from the UAB Gorgas Institute (2024), an MD from the Medical University of South Carolina (2020), and a BS from the University of South Carolina (2012). Her academic foundation bridges basic science, clinical medicine, and global public health. Through her education, she developed a strong interdisciplinary skill set, preparing her to tackle complex healthcare challenges both locally and globally. Her continuous academic advancement illustrates a deep commitment to lifelong learning and evidence-based medicine, solidifying her as a thoughtful scholar-practitioner in the field of emergency medicine.

Professional Experience

Dr. Shaw brings robust clinical and academic experience, currently serving as an Emergency Medicine physician at UAB Hospital and Children’s of Alabama. She completed her EM residency at LSU Health Shreveport (2023) and is a current GEM/SEMPH fellow at UAB. Her roles include academic instruction, research mentorship, and frontline emergency care. Beyond clinical duties, she has served as co-director and advisor for medical student organizations, led curriculum development, and collaborated on international health initiatives. Her leadership extends to free clinics, global outreach, and medical education. This diverse experience showcases her ability to integrate patient care, teaching, and research, reinforcing her qualifications for academic recognition.

Research Interests

Dr. Shaw’s research centers on health disparities, emergency care for vulnerable populations, provider education, and global health systems. Her projects include healthcare needs assessments for people experiencing homelessness, provider preferences in airway management, and the use of ultrasound in resource-limited settings. She also explores the intersection of housing insecurity and substance use in emergency settings. With training in tropical medicine and public health, she integrates clinical findings with systemic solutions to improve patient outcomes. Dr. Shaw’s commitment to applied, community-informed research reflects a broader vision to improve emergency care delivery and public health infrastructure locally and globally.

Awards and Honors

Dr. Shaw has received numerous academic and research honors, including first place at the 2022 EMerald Coast Conference for her intubation simulation study. As an undergraduate, she earned the Magellan Scholar Research Grant, Discovery Day 1st Place in Biology Research, and Who’s Who Among America’s Universities recognition. In medical school, she received the Milton Paul Kleinholz Endowed Scholarship at Meharry Medical College. These accolades reflect her long-standing commitment to academic excellence and impactful research. Her record of award-winning work across different stages of her career underscores her potential as a leader in medical research and supports her candidacy for further recognition.

Conclusion

Dr. Christine Marie Shaw is a strong candidate for the Best Researcher Award in the early-career category. Her academic rigor, service-oriented mindset, and award-winning research mark her as a future leader in emergency medicine scholarship. While still developing her research portfolio, her trajectory reflects significant promise and alignment with the award’s goals.

Publications Top Notes

Shoubhik Chakraborty | Health Professions | Best Researcher Award

Posted on by Shen Awards

Dr. Shoubhik Chakraborty | Health Professions | Best Researcher Award

Pediatric optometrist from Kalinga Institute of Medical Science, India

Shoubhik Chakraborty is a committed and dynamic professional in the field of Clinical Optometry, specializing in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment (CVI). He holds a Bachelor’s degree in Clinical Optometry and Vision Science from NSHM College of Management and Technology, affiliated with MAKAUT. His professional journey is marked by practical clinical experience and a keen interest in advanced vision therapy. Shoubhik has worked with prestigious institutions like Narayana Nethralaya, AIIMS Jodhpur, and currently serves as a Pediatric Optometrist at KIMS, Bhubaneswar. He has demonstrated his research capabilities through multiple scientific publications in peer-reviewed journals. Throughout his career, he has attended major optometry conferences, reflecting his commitment to professional development and learning. With a blend of strong clinical acumen, research enthusiasm, and a drive for innovation in optometry, Shoubhik is poised to contribute meaningfully to the advancement of pediatric vision care. His passion for restoring and enhancing vision, especially among children and individuals with neurological visual impairments, is evident in both his clinical work and academic pursuits. He brings a mix of leadership, creativity, and critical thinking to every assignment, showing potential for further academic and clinical excellence.

Professional Profile

Education

Shoubhik Chakraborty’s educational background showcases a strong foundation in optometry and vision science. He completed his secondary education at Sagardighi Thermal Power School (2014–2015) under the West Bengal Board of Secondary Education (WBBSE) and his higher secondary studies at Karaiya High School (2015–2017) affiliated with the West Bengal Council of Higher Secondary Education (WBCHSE). Building on his early academic success, he pursued a Bachelor’s degree in Clinical Optometry and Vision Science (2017–2021) at NSHM College of Management and Technology, under MAKAUT. During his academic years, he completed vocational training at Susrut Eye Foundation and Research Centre, Kolkata, and undertook a comprehensive internship at MGM Eye Institute, Raipur, Chhattisgarh. Recognizing the importance of specialized training, Shoubhik further pursued a Fellowship in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment from Narayana Nethralaya, Bangalore, which he completed between August 2021 and January 2023. His academic background has been complemented by seminars, workshops, and continuous learning in vision therapy and neuro-optometry, equipping him with the latest techniques and research-based practices in his field.

Professional Experience

Shoubhik Chakraborty’s professional journey reflects a strong commitment to clinical excellence and research-oriented optometry practice. After completing his Bachelor’s degree and internship, he pursued a Fellowship at Narayana Nethralaya, Bangalore, specializing in Pediatric Optometry, Binocular Vision, and Cerebral Visual Impairment. Post-fellowship, Shoubhik worked as a Cerebral Visual Impairment Specialist at the prestigious All India Institute of Medical Sciences (AIIMS), Jodhpur, from February 2023 to August 2023. His role at AIIMS involved specialized diagnosis, management, and vision therapy for children with complex neurological visual disorders. Currently, he is employed as a Pediatric Optometrist at KIMS, Bhubaneswar, where he continues to apply and expand his clinical and research expertise. His clinical practice integrates evidence-based methods for treating amblyopia, strabismus, and CVI, and he remains actively involved in patient-centered therapy programs. Shoubhik’s career also includes participation in national conferences, presenting his findings and staying updated with the latest advancements in pediatric and behavioral optometry. His hands-on experience across multiple renowned institutions, combined with research activities and a focus on clinical innovation, positions him as a promising healthcare professional with aspirations for greater leadership in optometry and vision research.

Research Interests

Shoubhik Chakraborty’s research interests center around Pediatric Optometry, Binocular Vision Anomalies, Cerebral Visual Impairment (CVI), Amblyopia Management, and Behavioral Optometry. He is particularly passionate about advancing the understanding of vision therapy and its long-term effects on children with neurological visual impairments. His work focuses on the development and validation of customized vision therapy programs aimed at improving binocular function, stereopsis, and visual acuity in children and young adults. He is also interested in studying the outcomes of early intervention therapies for amblyopia, anisometropia, and CVI, and their impact on patients’ overall quality of life. Shoubhik actively explores neuroplasticity and rehabilitation strategies to help children with brain injuries or developmental delays regain visual function. His goal is to bridge clinical practice and research by developing standardized protocols for vision therapy and contributing to evidence-based pediatric optometry. Furthermore, he is keen on future research collaborations that integrate neuro-optometric rehabilitation with technological innovations such as digital therapies and telehealth models to expand access to specialized vision care services.

Research Skills

Shoubhik Chakraborty possesses a wide range of research and clinical skills critical to his specialization. His research competencies include designing and executing clinical studies, performing statistical analysis of therapy outcomes, critical literature review, and drafting manuscripts for peer-reviewed publication. In clinical practice, he is skilled in the assessment and management of binocular vision disorders, orthoptic evaluations, pediatric visual development assessments, and neuro-optometric rehabilitation for CVI patients. Shoubhik also demonstrates proficiency in customized vision therapy techniques, including anti-suppression therapy, vergence therapy, and accommodative facility enhancement. His training has equipped him with the ability to critically analyze therapy outcomes and continuously refine intervention strategies. He has excellent skills in decision-making, critical thinking, creativity, teamwork, and leadership, which are crucial for multidisciplinary collaboration in clinical research settings. He also holds a diploma in computer applications, enabling him to efficiently manage patient data, conduct research documentation, and prepare presentations. Shoubhik’s ability to merge research rigor with clinical sensitivity makes him well-suited for future roles involving innovation in pediatric optometry and vision science.

Awards and Honors

Shoubhik Chakraborty’s academic and professional journey has been marked by notable achievements and recognitions. His most significant honors come through his contributions to scientific publications in reputed optometry journals. His case study on restoring binocular vision in a 23-year-old myopic anisometropic amblyopia patient was published in Optometry and Visual Performance (October 2023). His retrospective study on the outcomes of vision therapy among children with Cerebral Visual Impairment was also accepted and published in Optometry and Visual Performance (March 2024). Furthermore, his research on the impact of active vision therapy on anisometropic amblyopia cases was published in EC Ophthalmology (September 2024). Beyond publishing, his participation in national-level conferences like the Asia Pacific Optometry Summit, Bengal Optometry Conference, Kolkata Optometry Conference, and Karnataka Optometry Conference demonstrates his active engagement in the professional community. His Fellowship in Pediatric Optometry and Cerebral Visual Impairment from Narayana Nethralaya is another key milestone that highlights his commitment to clinical and academic excellence. These achievements position him as a promising young optometrist with potential for greater recognition and leadership in vision science.

Conclusion

In conclusion, Shoubhik Chakraborty is a highly motivated and emerging professional in the field of optometry, showing commendable progress in both clinical practice and research. His educational background, fellowship training, and hands-on experience with specialized populations such as children with Cerebral Visual Impairment underline his dedication to advancing pediatric vision care. His publications in peer-reviewed journals demonstrate his ability to contribute meaningful research to the field. With strong clinical skills, research acumen, leadership qualities, and a commitment to continuous learning, Shoubhik is well-positioned to make significant contributions to pediatric optometry and vision therapy research. To further strengthen his professional trajectory, he could consider expanding his research portfolio through multicenter studies and pursuing advanced degrees such as a Master’s or Ph.D. Overall, Shoubhik embodies the qualities of a future leader in clinical optometry and research, and he is well-deserving of encouragement and support for higher academic and professional achievements.

Publications Top Notes

  • Recovering Vision and Binocularity in a Presbyopic Patient with Amblyopia
    Authors: SD Shoubhik Chakraborty, Hajira R
    Journal: VDR, Vol. 11(1), p. 48
    Year: 2025

  • Prevalence of Accommodative Insufficiency in Children With Normal Accommodative-Convergence/Accommodation Ratio and Its Association With Refractive Error: A Cross-Sectional Study
    Authors: S Chakraborty, S Parida, SK Mohanty, M Das, S Dash, S Mohanty
    Journal: Cureus, Vol. 17(2)
    Year: 2025

  • The Role of Vision Therapy in the Management of Recurrent Hordeolum
    Authors: S Chakraborty, PP Sahu, SK Mohanty, R Hajira
    Year: 2025

  • Treatment of Anisometropic Amblyopia Using a Combination Approach
    Authors: HR Shoubhik Chakraborty, Shrutakirty Parida
    Journal: VDR, Vol. 10(4), p. 187
    Year: 2024

  • The Impact of Active Vision Therapy on Vision and Binocularity for Anisometropic Amblyopia Cases
    Authors: SR Shoubhik Chakraborty, Shrutakirty Parida, Sahanaz Hossain
    Journal: EC Ophthalmology
    Year: 2024

  • Outcomes Of Vision Therapy Among Children with Cerebral Visual Impairment: A Retrospective Study
    Authors: S Chakraborty, P Sarbajna, A Vinekar, B Shetty
    Journal: Optometry & Visual Performance, Vol. 12(1)
    Year: 2024

  • Case Report: Enhancing Binocular Vision of an Adult with Anisometropic Amblyopia
    Authors: S Chakraborty, P Sarbajna, A Vinekar, B Shetty
    Journal: Optometry & Visual Performance, Vol. 11(3)
    Year: 2023

  • Treatment of Anisometropic Amblyopia Using a Combination Approach (Duplicate Title)
    Authors: S Chakraborty, B Optom, S Parida, R Hajira

  • Let’s Delve Into the Least Explored Visual Pathway
    Author: S Chakraborty

Xia Chen | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Ms. Xia Chen | Medicine and Dentistry |  Best Researcher Award

Professor from Yunnan Provincial Hospital of Chinese Medicine, China

Xia Chen is an accomplished chief physician, professor, and master’s supervisor, specializing in integrated Chinese and Western medicine, particularly in gastroenterology. Born in 1978 in Yunnan, China, she has devoted more than two decades to clinical practice, teaching, and scientific research. Currently, she serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. She has gained recognition as an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province and holds membership in the Hepatobiliary Disease Branch of the Chinese Medical Association. Her career focuses on the diagnosis and treatment of digestive diseases using both traditional Chinese medicine and Western medicine approaches. Xia Chen’s contribution extends beyond clinical work to research projects, drug trials, and academic publishing. Her ability to bridge traditional and modern medical practices has made her a notable figure in her field. Over the years, she has led and participated in numerous prestigious research projects and has authored or co-authored several scholarly works. Xia Chen’s career reflects dedication to improving healthcare outcomes through integrated medicine and advancing research in digestive health, making her a leader in her specialty and an inspiration for future researchers and clinicians.

Professional Profile

Education

Although detailed information about Xia Chen’s educational background is not explicitly provided, her current standing as a chief physician and professor suggests a comprehensive academic journey in medicine, likely beginning with a bachelor’s degree in traditional Chinese medicine or clinical medicine. Following her undergraduate studies, it is plausible she pursued further specialization, completing advanced degrees, possibly a master’s degree or doctorate, focusing on integrated Chinese and Western medicine with a specialty in digestive diseases. Xia Chen’s position as a master’s supervisor also indicates her formal academic qualification aligns with national standards for academic leadership roles in China, which typically require at least a master’s degree combined with significant clinical expertise. Her education would have provided her a strong foundation in traditional Chinese medical principles, combined with extensive training in modern clinical practices, pharmacology, and research methodology. Given her leadership in research projects and teaching, she likely continued her professional development through certifications, clinical fellowships, and continuous medical education programs. Her educational journey underpins her expertise in gastroenterology and serves as the backbone for her clinical, academic, and research excellence.

Professional Experience

Xia Chen has built a remarkable professional career, accumulating over 20 years of experience in clinical practice, teaching, and research in the field of integrated Chinese and Western medicine. She currently serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. Her daily responsibilities include diagnosing and treating patients with complex digestive diseases, mentoring master’s students, and overseeing research activities. She has established herself as a specialist who skillfully combines traditional Chinese medical therapies with modern Western treatments, offering holistic and effective patient care. Xia Chen’s leadership extends to supervising clinical trials and participating in national Phase II, III, and IV drug research studies. Her practical skills are complemented by her academic contributions, which include teaching future healthcare professionals and guiding research initiatives. Furthermore, she actively contributes to healthcare policy improvements through her roles in professional associations such as the Hepatobiliary Disease Branch of the Chinese Medical Association. Her professional experience highlights her comprehensive expertise across clinical, academic, and scientific domains, making her a pivotal figure in advancing the integration of traditional Chinese medicine with contemporary medical science.

Research Interests

Xia Chen’s research interests focus on the integration of traditional Chinese medicine and Western medicine approaches to digestive diseases. A significant part of her work explores the therapeutic effects of natural medicines on intestinal dynamics. Her research aims to scientifically validate the efficacy of traditional remedies and their mechanisms of action, thereby bridging the gap between ancient practices and modern clinical science. Additionally, Xia Chen is deeply interested in clinical trials related to new drug developments, having participated in numerous national Phase II, III, and IV studies. Her research spans studying gastrointestinal motility disorders, chronic digestive conditions, and hepatobiliary diseases. She is particularly motivated by the desire to develop more effective, less invasive, and side-effect-minimized treatments through integrative approaches. Another important research area for Xia Chen is understanding how traditional Chinese formulations can complement or enhance the effects of Western pharmacological interventions. Her research is highly practical, patient-centered, and innovative, targeting improvements in clinical outcomes. With a growing emphasis on evidence-based medicine, her work contributes significantly to validating and modernizing traditional Chinese medicinal practices while maintaining their historical integrity and therapeutic richness.

Research Skills

Xia Chen possesses a broad range of research skills that have been instrumental in her professional success. She demonstrates expertise in designing and conducting clinical trials, especially those combining traditional Chinese medicinal approaches with Western methodologies. Her skill set includes protocol development, patient recruitment and management, data analysis, and reporting in accordance with national and international standards. She is proficient in evaluating the pharmacological effects of natural medicines and their applications in digestive health. Xia Chen’s publication record highlights her ability to carry out longitudinal studies and synthesize findings for publication in peer-reviewed journals. Her role as a master’s supervisor also reflects her ability to guide young researchers in research design, methodology, and thesis writing. Furthermore, her participation in over ten national drug studies indicates advanced skills in regulatory compliance, clinical pharmacology, and interdisciplinary collaboration. Xia Chen’s integrated approach to traditional and modern research paradigms exemplifies her unique strengths. Her research methodology is thorough, combining qualitative insights from traditional Chinese medicine with the quantitative rigor required in modern clinical research. These combined skills make her a formidable researcher capable of making impactful contributions to the field.

Awards and Honors

Throughout her distinguished career, Xia Chen has received notable awards and honors recognizing her professional and academic contributions. She has been named an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province, an accolade that underscores her clinical excellence, research innovation, and contributions to the advancement of traditional Chinese medicine. Her appointment as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at the Yunnan Provincial Hospital of Chinese Medicine is itself a recognition of her expertise and leadership capabilities. Furthermore, her active membership in the Hepatobiliary Disease Branch of the Chinese Medical Association reflects national recognition of her skills and knowledge. These honors highlight her respected position within the Chinese medical community. They also affirm her commitment to bridging traditional Chinese medicine with modern clinical practices. While specific awards for research publications or international recognition have not been detailed, her extensive leadership in research projects and contribution to multiple monographs reinforce her academic and professional stature. Xia Chen’s awards and honors validate her significant and ongoing impact in the field of integrated medicine and gastroenterology.

Conclusion

Xia Chen is a highly accomplished clinician, educator, and researcher whose career embodies excellence in integrating traditional Chinese and Western medical practices. Her dedication to advancing digestive health through innovative, interdisciplinary methods sets her apart as a leader in her field. With over two decades of professional experience, leadership in major research projects, and numerous scholarly contributions, she has significantly impacted both clinical practice and academic research. Her recognition as an Outstanding Young Practitioner of Chinese Medicine and leadership roles within national medical organizations reflect her esteemed reputation. While opportunities exist for expanding her international research presence, Xia Chen’s current achievements already demonstrate her remarkable expertise, commitment, and influence. She serves as a bridge between ancient medical wisdom and contemporary science, promoting holistic and evidence-based healthcare solutions. As she continues to build on her impressive body of work, Xia Chen is poised to make even greater contributions to global medical science, ensuring that traditional Chinese medicine remains relevant, respected, and scientifically validated in the modern era.

Publications Top Notes

  • Title: Quercetin Inhibits Cardiomyocyte Apoptosis via Sirt3/SOD2/Mitochondrial Reactive Oxygen Species During Myocardial Ischemia–Reperfusion Injury

  • Authors: Xiong Da, Wang Xin, Wang Haiyu, Zhao Zicong, Ren Wenjun

  • Year: 2024

  • Citations: 6